meningioma
Conditions
Interventions
None listed
Sponsors
Oya Soichi Soichi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with recurrent WHO grade 1 meningioma or WHO grade 2/3 meningioma who have undergone surgical resection at participating institutions from 2001 to the start of this study , who have completed the necessary medical examinations, whose residual specimens are stored, and who have already given consent for use in medical research in general, including genetic analysis, are included in this study. The patients who have already given consent for the use of their specimens for genetic analysis and other medical research are also included in the study. In addition, patients with newly diagnosed recurrent WHO grade 1 meningioma or WHO grade 2/3 meningioma who have undergone resection after the start of this study at the participating institutions are included if their consent for use in this study has been obtained at each institution for the remaining specimens after all necessary tests for treatment have been performed. Blood samples will also be collected from patients who fall into any of the above categories and who consent to have their blood samples collected.
Exclusion criteria
Exclusion criteria: Patients for whom consent for participation in the study described in "9. Methods of Obtaining Subjects' Understanding and Consent" in the research protocol can not be obtained are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| recurrence, follow-up period | — |
Contacts
Public ContactOya Soichi
Saitama Medical Center/University
Outcome results
None listed